Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fink

Showing results (21-30 of 418) with videos related to

Pageof 42
Sort By:
Intensive Care Medicine|March 22, 2002
Clinical tests of gastrointestinal permeability that rely on the urinary recovery of enterally administered probes can yield invalid results in critically ill patientsMitchell P Fink
Critical Care Clinics|March 26, 2002
Cytopathic hypoxia. Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration?Mitchell P Fink
Kidney International|October 2, 2008
Animal models of sepsis and its complicationsMitchell P Fink
Critical Care (London, England)|July 17, 2014
HMGB1 as a drug target in staphylococcal pneumoniaMitchell P Fink
Journal of Leukocyte Biology|March 3, 2010
Editorial: Lepromatous leprosy, lipids, and lessons in immunology: what we can learn by using modern methods to study an ancient diseaseMitchell P Fink
The Journal of Antimicrobial Chemotherapy|March 25, 1998
Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsisM P Fink
Minerva Anestesiologica|June 8, 2004
Ethyl pyruvate: a novel treatment for sepsis and shockM P Fink
Critical Care Medicine|February 6, 2004
Peroxisome proliferator-activated receptor-gamma ligands: a pluripotent class of pharmacological agents that may prove to be useful for adjuvant treatment of sepsis and multiple organ dysfunction syndromeMitchell P Fink
Critical Care Medicine|September 17, 2015
Integrated Critical Care Organizations: A Personal ViewMitchell P Fink
Critical Care Medicine|October 3, 1999
Modulating the L-arginine-nitric oxide pathway in septic shock: choosing the proper point of attackM P Fink
Pageof 42

Showing results (21-30 of 418) with videos related to

Sort By:
Pageof 42
Intensive Care Medicine|March 22, 2002
Clinical tests of gastrointestinal permeability that rely on the urinary recovery of enterally administered probes can yield invalid results in critically ill patientsMitchell P Fink
Critical Care Clinics|March 26, 2002
Cytopathic hypoxia. Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration?Mitchell P Fink
Kidney International|October 2, 2008
Animal models of sepsis and its complicationsMitchell P Fink
Critical Care (London, England)|July 17, 2014
HMGB1 as a drug target in staphylococcal pneumoniaMitchell P Fink
Journal of Leukocyte Biology|March 3, 2010
Editorial: Lepromatous leprosy, lipids, and lessons in immunology: what we can learn by using modern methods to study an ancient diseaseMitchell P Fink
The Journal of Antimicrobial Chemotherapy|March 25, 1998
Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsisM P Fink
Minerva Anestesiologica|June 8, 2004
Ethyl pyruvate: a novel treatment for sepsis and shockM P Fink
Critical Care Medicine|February 6, 2004
Peroxisome proliferator-activated receptor-gamma ligands: a pluripotent class of pharmacological agents that may prove to be useful for adjuvant treatment of sepsis and multiple organ dysfunction syndromeMitchell P Fink
Critical Care Medicine|September 17, 2015
Integrated Critical Care Organizations: A Personal ViewMitchell P Fink
Critical Care Medicine|October 3, 1999
Modulating the L-arginine-nitric oxide pathway in septic shock: choosing the proper point of attackM P Fink
Pageof 42